Andra AP fonden Buys 26,900 Shares of Universal Health Services, Inc. $UHS

Andra AP fonden raised its position in Universal Health Services, Inc. (NYSE:UHSFree Report) by 18.0% during the second quarter, HoldingsChannel.com reports. The firm owned 176,410 shares of the health services provider’s stock after purchasing an additional 26,900 shares during the period. Andra AP fonden’s holdings in Universal Health Services were worth $31,957,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in UHS. Zions Bancorporation National Association UT purchased a new stake in shares of Universal Health Services in the 1st quarter worth approximately $30,000. First Horizon Advisors Inc. increased its stake in Universal Health Services by 347.6% during the 2nd quarter. First Horizon Advisors Inc. now owns 188 shares of the health services provider’s stock valued at $34,000 after purchasing an additional 146 shares in the last quarter. Huntington National Bank grew its stake in Universal Health Services by 240.0% during the 2nd quarter. Huntington National Bank now owns 204 shares of the health services provider’s stock valued at $37,000 after purchasing an additional 144 shares during the last quarter. Federated Hermes Inc. raised its position in Universal Health Services by 89.7% during the 1st quarter. Federated Hermes Inc. now owns 258 shares of the health services provider’s stock worth $48,000 after buying an additional 122 shares during the last quarter. Finally, Farther Finance Advisors LLC boosted its holdings in Universal Health Services by 22.9% in the second quarter. Farther Finance Advisors LLC now owns 354 shares of the health services provider’s stock valued at $64,000 after purchasing an additional 66 shares during the last quarter. Hedge funds and other institutional investors own 86.05% of the company’s stock.

Universal Health Services Stock Performance

NYSE:UHS opened at $227.74 on Thursday. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.03 and a quick ratio of 1.19. The firm’s fifty day moving average price is $200.38 and its 200 day moving average price is $185.95. Universal Health Services, Inc. has a 1-year low of $152.33 and a 1-year high of $228.08. The firm has a market cap of $14.49 billion, a price-to-earnings ratio of 10.82, a price-to-earnings-growth ratio of 0.80 and a beta of 1.30.

Universal Health Services (NYSE:UHSGet Free Report) last announced its quarterly earnings results on Monday, October 27th. The health services provider reported $5.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.66 by $1.03. The business had revenue of $4.50 billion during the quarter, compared to the consensus estimate of $4.32 billion. Universal Health Services had a net margin of 8.09% and a return on equity of 19.47%. The business’s revenue was up 13.4% compared to the same quarter last year. During the same quarter last year, the firm posted $3.71 EPS. Universal Health Services has set its FY 2025 guidance at 21.500-22.100 EPS. On average, sell-side analysts expect that Universal Health Services, Inc. will post 15.92 EPS for the current year.

Insider Activity

In other news, Director Elliot J. Md Mba Sussman sold 965 shares of the firm’s stock in a transaction on Wednesday, October 29th. The stock was sold at an average price of $225.70, for a total transaction of $217,800.50. Following the sale, the director owned 6,113 shares in the company, valued at $1,379,704.10. This trade represents a 13.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 16.40% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on UHS shares. JPMorgan Chase & Co. dropped their price objective on shares of Universal Health Services from $215.00 to $195.00 and set a “neutral” rating on the stock in a research note on Monday, August 4th. Guggenheim increased their price objective on Universal Health Services from $227.00 to $253.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Weiss Ratings restated a “hold (c+)” rating on shares of Universal Health Services in a research report on Wednesday, October 8th. Zacks Research raised shares of Universal Health Services from a “hold” rating to a “strong-buy” rating in a research note on Monday, October 27th. Finally, Wall Street Zen upgraded Universal Health Services from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 11th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $233.20.

Check Out Our Latest Research Report on Universal Health Services

About Universal Health Services

(Free Report)

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.

Featured Articles

Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHSFree Report).

Institutional Ownership by Quarter for Universal Health Services (NYSE:UHS)

Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.